Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer among U.S. Women with Breast Cancer

IMPORTANCE: Within ten years after breast cancer diagnosis, 5% of patients develop contralateral primary breast cancer (CBC). Randomized trials have found that tamoxifen and aromatase inhibitors (AIs) reduce CBC risk. However, little is known about the magnitude and duration of protective effects wi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Oncol
Autori principali: Gierach, Gretchen L., Curtis, Rochelle E., Pfeiffer, Ruth M., Mullooly, Maeve, Ntowe, Estelle A., Hoover, Robert N., Nyante, Sarah J., Feigelson, Heather Spencer, Glass, Andrew G., de Gonzalez, Amy Berrington
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757540/
https://ncbi.nlm.nih.gov/pubmed/27711920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.3340
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi